What Can You Expect at the Rare Epilepsy & DEE Drug Development Summit?
The Rare Epilepsy & DEE Drug Development Summit is the definitive meeting for biopharma leaders developing transformative therapies for rare epilepsies. Uniting the companies, experts, and advocates at the forefront of the field, this industry-led forum provides a unique opportunity to engage in honest, high-value conversations on the scientific, clinical, regulatory, and commercial challenges defining success. More than just another conference, it is where the rare epilepsy community comes together to build relationships, exchange hard-earned lessons, and accelerate the path to meaningful patient impact.
Across three days of in-depth discussion, you'll learn directly from the organizations leading innovation across ASOs, gene therapies, RNA-targeted medicines, precision small molecules, and novel disease-modifying approaches.
Join peers from Biogen, Lundbeck, Ionis Pharmaceuticals, Jazz Pharmaceuticals, Encoded, GRIN Therapeutics, and more to benchmark development strategies, identify new opportunities, and accelerate progress toward meaningful patient outcomes beyond seizure control.
Unmissable Event Highlights
Discover how leading developers are building disease-modifying therapies that move beyond symptomatic seizure control
Learn how biomarkers, EEG technologies, and novel endpoints are shaping regulatory success
Explore the future of ASOs, gene therapies, RNA medicines, and precision small molecules
Benchmark patient stratification, recruitment, and trial design strategies for ultra-rare populations
Understand payer, reimbursement, partnership, and commercialization considerations for advanced therapies
Network with senior leaders across translational, clinical, medical, and executive functions
Attending Companies Include
Explore the Full Event Guide
- 18+ expert speakers from leading rare epilepsy innovators
- 2 interactive workshops dedicated to translational models and clinical trial optimization
- 3 panel & roundtable discussions tackling the field's biggest challenges
- 60+ senior biopharma leaders across R&D, clinical, translational and executive functions
- Dedicated coverage of ASOs, gene therapies, RNA medicines & precision small molecules
Explore the Event Guide
Explore the complete speaker faculty, agenda, workshops, and networking opportunities.
Partner With the Community
Position your organization alongside the companies shaping the future of rare epilepsy drug development.
Secure Your Place
Join senior leaders advancing precision and disease-modifying therapies for rare epilepsies and DEEs.